Hmp_logo

Human Metabolome Database Version 3.5

HMDB has recently undergone some major changes, if you are experiencing problems please click here to provide us with feedback.

Showing metabocard for Theobromine (HMDB02825)

Record Information
Version 3.5
Creation Date 2006-05-22 09:12:12 -0600
Update Date 2013-05-21 14:23:58 -0600
HMDB ID HMDB02825
Secondary Accession Numbers None
Metabolite Identification
Common Name Theobromine
Description Theobromine, or 3,7-Dimethylxanthine, is the principle alkaloid in Theobroma cacao (the cacao bean) and other plants. A xanthine alkaloid that is used as a bronchodilator and as a vasodilator. It has a weaker diuretic activity than theophylline and is also a less powerful stimulant of smooth muscle. It has practically no stimulant effect on the central nervous system. It was formerly used as a diuretic and in the treatment of angina pectoris and hypertension. (From Martindale, The Extra Pharmacopoeia, 30th ed, pp1318-9, as cited on Pubchem). Theobromine is a bitter alkaloid of the methylxanthine family, which also includes the similar compounds theophylline and caffeine. Despite its name, the compound contains no bromine. Theobromine is derived from Theobroma, the genus of the cacao tree, which is composed of the Greek roots theo ("God") and broma ("food"), meaning "food of the gods". It is the primary alkaloid found in cocoa and chocolate, and is one of the causes for chocolate's mood-elevating effects. The amount found in chocolate is small enough that chocolate can be safely consumed by humans in large quantities, but animals that metabolize theobromine more slowly, such as cats and dogs, can easily consume enough chocolate to cause chocolate poisoning. Theobromine is a stimulant frequently confused with caffeine. Theobromine has very different effects on the human body from caffeine; it is a mild, lasting stimulant with a mood improving effect, whereas caffeine has a strong, immediate effect and increases stress. In medicine, it is used as a diuretic, vasodilator, and myocardial stimulant. There is a possible association between prostate cancer and theobromine. Theobromine is a contributing factor in acid reflux because it relaxes the esophageal sphincter muscle, allowing stomach acid access to the esophagus (Wikipedia).
Structure Thumb
Download: MOL | SDF | SMILES | InChI
Display: 2D Structure | 3D Structure
Synonyms
  1. Teobromin
  2. 2,6-Dihydroxy-3,7-dimethyl-purine
  3. 3,7-Dimethyl-xanthine
  4. Diurobromine
  5. Theobromine
Chemical Formula C7H8N4O2
Average Molecular Weight 180.164
Monoisotopic Molecular Weight 180.06472552
IUPAC Name 3,7-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione
Traditional IUPAC Name theobromine
CAS Registry Number 83-67-0
SMILES CN1C=NC2=C1C(=O)NC(=O)N2C
InChI Identifier InChI=1S/C7H8N4O2/c1-10-3-8-5-4(10)6(12)9-7(13)11(5)2/h3H,1-2H3,(H,9,12,13)
InChI Key YAPQBXQYLJRXSA-UHFFFAOYSA-N
Chemical Taxonomy
Kingdom Organic Compounds
Super Class Aromatic Heteropolycyclic Compounds
Class Imidazopyrimidines
Sub Class Purines and Purine Derivatives
Other Descriptors
  • Organic Compounds
  • Purine alkaloids(KEGG)
  • Purinones
  • a small molecule(Cyc)
  • dimethylxanthine(ChEBI)
Substituents
  • Imidazole
  • Pyrimidine
  • Pyrimidone
Direct Parent Xanthines
Ontology
Status Detected and Quantified
Origin
  • Drug metabolite
  • Plant
Biofunction
  • Waste products
Application Not Available
Cellular locations
  • Cytoplasm (predicted from logP)
Physical Properties
State Solid
Experimental Properties
Property Value Reference
Melting Point 357 °C Not Available
Boiling Point Not Available Not Available
Water Solubility 0.33 mg/mL at 25 °C Not Available
LogP -0.78 HANSCH,C ET AL. (1995)
Predicted Properties
Property Value Source
Water Solubility 9.74 g/L ALOGPS
LogP -0.46 ALOGPS
LogP -0.77 ChemAxon
LogS -1.27 ALOGPS
pKa (strongest acidic) 9.28 ChemAxon
pKa (strongest basic) -0.91 ChemAxon
Hydrogen Acceptor Count 3 ChemAxon
Hydrogen Donor Count 1 ChemAxon
Polar Surface Area 67.23 A2 ChemAxon
Rotatable Bond Count 0 ChemAxon
Refractivity 44.93 ChemAxon
Polarizability 16.85 ChemAxon
Formal Charge 0 ChemAxon
Physiological Charge 0 ChemAxon
Spectra
1H NMR Spectrum
MS/MS Spectrum Quattro_QQQ 10
MS/MS Spectrum Quattro_QQQ 25
MS/MS Spectrum Quattro_QQQ 40
MS/MS Spectrum EI-B (Unknown)
MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10
MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 20
MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 30
MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 40
MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 50
MS/MS Spectrum GC-MS
[1H,13C] 2D NMR Spectrum
Biological Properties
Cellular Locations
  • Cytoplasm (predicted from logP)
Biofluid Locations
  • Blood
  • Cerebrospinal Fluid (CSF)
  • Urine
Tissue Location
  • Kidney
  • Liver
Pathways
Name SMPDB Link KEGG Link
Caffeine Metabolism SMP00028 map00232 Link_out
Normal Concentrations
Biofluid Status Value Age Sex Condition Reference
Blood Detected and Quantified
1.1 +/- 0.2 uM Adult (>18 years old) Male Normal
Urine Detected but not Quantified
Not Applicable Adult (>18 years old) Both Normal
Urine Detected and Quantified
0.5 (0.36-0.7) umol/mmol creatinine Adult (>18 years old) Both Normal
Abnormal Concentrations
Biofluid Status Value Age Sex Condition Reference
Blood Detected and Quantified 1.3 +/- 0.5 uM Adult (>18 years old) Male Comment Malaria
Cerebrospinal Fluid (CSF) Detected and Quantified 0.869 +/- 0.182 uM Adult (>18 years old) Both severe traumatic brain injury (TBI)
Cerebrospinal Fluid (CSF) Detected and Quantified 1.710 +/- 0.539 uM Not Specified Not Specified Traumatic Brain Injury (TBI)
Cerebrospinal Fluid (CSF) Detected and Quantified 0.641 +/- 0.169 uM Not Specified Not Specified Traumatic Brain Injury (TBI)
Cerebrospinal Fluid (CSF) Detected and Quantified 0.863 +/- 0.241 uM Not Specified Female Traumatic Brain Injury (TBI)
Cerebrospinal Fluid (CSF) Detected and Quantified 0.886 +/- 0.185 uM Not Specified Male Traumatic Brain Injury (TBI)
Urine Detected but not Quantified Not Applicable Adult (>18 years old) Both Autosomal dominant polycystic kidney disease
Urine Detected and Quantified 3.6 (1.0-7.3) umol/mmol creatinine Adult (>18 years old) Both Comment Asthma
Associated Disorders and Diseases
Disease References
Malaria
  • Akinyinka OO, Sowunmi A, Honeywell R, Renwick AG: The effects of acute falciparum malaria on the disposition of caffeine and the comparison of saliva and plasma-derived pharmacokinetic parameters in adult Nigerians. Eur J Clin Pharmacol. 2000 May;56(2):159-65. Pubmed: 10877011 Link_out
    Asthma
    • Zydron M, Baranowski J, Baranowska I: Separation, pre-concentration, and HPLC analysis of methylxanthines in urine samples. J Sep Sci. 2004 Oct;27(14):1166-72. Pubmed: 15537072 Link_out
      Associated OMIM IDs
      DrugBank ID DB01412 Link_out
      DrugBank Metabolite ID Not Available
      Phenol Explorer Compound ID Not Available
      Phenol Explorer Metabolite ID Not Available
      FoodDB ID FDB000455
      KNApSAcK ID C00001509 Link_out
      Chemspider ID 5236 Link_out
      KEGG Compound ID C07480 Link_out
      BioCyc ID 3-7-DIMETHYLXANTHINE Link_out
      BiGG ID Not Available
      Wikipedia Link Theobromine Link_out
      NuGOwiki Link HMDB02825 Link_out
      Metagene Link HMDB02825 Link_out
      METLIN ID 1456 Link_out
      PubChem Compound 5429 Link_out
      PDB ID 37T Link_out
      ChEBI ID 28946 Link_out
      References
      Synthesis Reference Yoon, Hye-Sung; Hwang, In-Gyun; Bang, Won-Gi. Production of theobromine from caffeine by Pseudomonas sp. Chayon Chawon Nonjip (1995), 35(1), 33-39.
      Material Safety Data Sheet (MSDS) Download (PDF)
      General References
      1. Tserng KY, King KC, Takieddine FN: Theophylline metabolism in premature infants. Clin Pharmacol Ther. 1981 May;29(5):594-600. Pubmed: 7214789 Link_out
      2. Gonzalez-Jimenez J, Frutos G, Cayre I: Fluorescence quenching of human serum albumin by xanthines. Biochem Pharmacol. 1992 Aug 18;44(4):824-6. Pubmed: 1510729 Link_out
      3. Holstege A, Kurz M, Weinbeck M, Gerok W: Excretion of caffeine and its primary degradation products into bile. J Hepatol. 1993 Jan;17(1):67-73. Pubmed: 8445222 Link_out
      4. Sommer KR, Hill RM, Horning MG: Identification and quantification of drugs in human amniotic fluid. Res Commun Chem Pathol Pharmacol. 1975 Nov;12(3):583-95. Pubmed: 1197933 Link_out
      5. Skopinska-Rozewska E, Janik P, Przybyszewska M, Sommer E, Bialas-Chromiec B: Inhibitory effect of theobromine on induction of angiogenesis and VEGF mRNA expression in v-raf transfectants of human urothelial cells HCV-29. Int J Mol Med. 1998 Dec;2(6):649-52. Pubmed: 9850731 Link_out
      6. Delahunty T, Schoendorfer D: Caffeine demethylation monitoring using a transdermal sweat patch. J Anal Toxicol. 1998 Nov-Dec;22(7):596-600. Pubmed: 9847011 Link_out
      7. Resman BH, Blumenthal P, Jusko WJ: Breast milk distribution of theobromine from chocolate. J Pediatr. 1977 Sep;91(3):477-80. Pubmed: 894424 Link_out
      8. Scott NR, Chakraborty J, Marks V: Determination of caffeine, theophylline and theobromine in serum and saliva using high-performance liquid chromatography. Ann Clin Biochem. 1984 Mar;21 ( Pt 2):120-4. Pubmed: 6712142 Link_out
      9. Emara S: Simultaneous determination of caffeine, theophylline and theobromine in human plasma by on-line solid-phase extraction coupled to reversed-phase chromatography. Biomed Chromatogr. 2004 Oct;18(8):479-85. Pubmed: 15386526 Link_out
      10. Gennaro MC, Abrigo C, Biglino P: Quantification of theophylline in human plasma by reversed-phase ion-interaction high-performance liquid chromatography and comparison with the TDx fluorescence polarization immunoassay procedure. Analyst. 1992 Jul;117(7):1071-4. Pubmed: 1524227 Link_out
      11. Desiraju RK, Sugita ET, Mayock RL: Determination of theophylline and its metabolites by liquid chromatography. J Chromatogr Sci. 1977 Dec;15(12):563-8. Pubmed: 591601 Link_out
      12. Blanchard J, Weber CW, Shearer LE: Methylxanthine levels in breast milk of lactating women of different ethnic and socioeconomic classes. Biopharm Drug Dispos. 1992 Apr;13(3):187-96. Pubmed: 1576327 Link_out
      13. Tarka SM Jr, Arnaud MJ, Dvorchik BH, Vesell ES: Theobromine kinetics and metabolic disposition. Clin Pharmacol Ther. 1983 Oct;34(4):546-55. Pubmed: 6617078 Link_out
      14. Sachse C, Ruschen S, Dettling M, Schley J, Bauer S, Muller-Oerlinghausen B, Roots I, Brockmoller J: Flavin monooxygenase 3 (FMO3) polymorphism in a white population: allele frequencies, mutation linkage, and functional effects on clozapine and caffeine metabolism. Clin Pharmacol Ther. 1999 Oct;66(4):431-8. Pubmed: 10546928 Link_out

      Enzymes
      Name: Xanthine dehydrogenase/oxidase
      Reactions:
      Theobromine + Water + Oxygen unknown 3,7-Dimethyluric acid + Hydrogen peroxide details
      Gene Name: XDH
      Uniprot ID: P47989 Link_out
      Protein Sequence: FASTA
      Gene Sequence: FASTA
      Name: cAMP-specific 3',5'-cyclic phosphodiesterase 4B
      Reactions: Not Available
      Gene Name: PDE4B
      Uniprot ID: Q07343 Link_out
      Protein Sequence: FASTA
      Gene Sequence: FASTA
      Name: Cytochrome P450 2E1
      Reactions: Not Available
      Gene Name: CYP2E1
      Uniprot ID: P05181 Link_out
      Protein Sequence: FASTA
      Gene Sequence: FASTA
      Name: Cytochrome P450 1A2
      Reactions: Not Available
      Gene Name: CYP1A2
      Uniprot ID: P05177 Link_out
      Protein Sequence: FASTA
      Gene Sequence: FASTA
      Name: Adenosine receptor A1
      Reactions: Not Available
      Gene Name: ADORA1
      Uniprot ID: P30542 Link_out
      Protein Sequence: FASTA
      Gene Sequence: FASTA
      Name: Adenosine receptor A2a
      Reactions: Not Available
      Gene Name: ADORA2A
      Uniprot ID: P29274 Link_out
      Protein Sequence: FASTA
      Gene Sequence: FASTA